TITLE

Infection Control in Cystic Fibrosis: Cohorting, Cross-Contamination, and the Respiratory Therapist

AUTHOR(S)
O'Malley, Catherine A.
PUB. DATE
May 2009
SOURCE
Respiratory Care;May2009, Vol. 54 Issue 5, p641
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cystic fibrosis (CF) is a complex genetic disease characterized by lung infections that lead to early morbidity and death. Pathogens that commonly infect the lungs of patients with CF include Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa, and Burkholderia cepacia. Aggressively treating pulmonary infection with antibiotics bas contributed to improved survival in patients with CF but bas also promoted muitiple-drug-resistant bacteria. Other complexities include the ability of bacteria to form biofilms. which makes them more resistant to antibiotics, and emerging pathogens in t F, of which the clinical importance is not yet clear. Increasing evidence of patient-to-patient transmission of CF pathogens led the Cystic Fibrosis Foundation to produce evidence-based infection-control recommendations, which stress 4 principles: standard precautions, transmission-based precautions, hand hygiene, and care of respiratory equipment. Respiratory therapists need to know and follow these infection-control recommendations. Coborting patients infected with B, cepacia complex is one of several interventions successful at keeping the spread of this pathogen low, but cohorting patients who are infected/colonized with other microbes is controversial, the main argument of which is not being certain of a patient's present respiratory culture status at any given patient visit.
ACCESSION #
40647426

 

Related Articles

  • Infection control update. Gillespie, Elizabeth // Australian Nursing Journal;Oct2009, Vol. 17 Issue 4, p35 

    The article discusses the developments in the efforts made for infection prevention and control. It notes that hand hygiene is regarded as the main measure for infection prevention. The threat posed by multi-drug resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE)...

  • Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile. Johnston, B. Lynn; Bryce, Elizabeth // CMAJ: Canadian Medical Association Journal;3/17/2009, Vol. 180 Issue 6, p627 

    The article reports on the strategies that will help prevent the spread of bacterial infections in hospitals in Canada. It reveals that hospitals have developed interventions which aims to prevent the spread of infections caused by the three leading antimicrobial-resistant pathogens, which are...

  • DEALING WITH THE HOSPITAL ACQUIRED INFECTIONS. Usman, Javaid // Pakistan Armed Forces Medical Journal;9/30/2014, Vol. 64 Issue 3, p382 

    The article focuses on how hospitals can address hospital acquired infections. Topics include the presence of some deadly pathogens in the hospital like methicillin resistant Staphylococcus aureus (MRSA), Acinetobacter species, and Clostridium difficile, the need to provide training to staff for...

  • IsaB Inhibits Autophagic Flux to Promote Host Transmission of Methicillin-Resistant Staphylococcus aureus. Liu, Pei-Feng; Cheng, Jin-Shiung; Sy, Cheng-Len; Huang, Wei-Chun; Yang, Hsiu-Chen; Gallo, Richard L; Huang, Chun-Ming; Shu, Chih-Wen // Journal of Investigative Dermatology;Nov2015, Vol. 135 Issue 11, p2714 

    Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a major nosocomial pathogen that is widespread in both health-care facilities and in the community at large, as a result of direct host-to-host transmission. Several virulence factors are associated with pathogen transmission to...

  • U of I targets treatment of 'superbug'.  // Journal of Business (10756124);12/6/2007, Vol. 22 Issue 25, pB8 

    The article focuses on the efforts of University of Idaho researchers to develop more effective defenses against staphylococcus aureaus bacteria and other deadly pathogens. One of the goals of the effort is to create faster and more accurate identification of infection strains resistant to the...

  • Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Spicuzza, L.; Sciuto, C.; Vitaliti, G.; Di Dio, G.; Leonardi, S.; La Rosa, M. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2009, Vol. 28 Issue 2, p191 

    In patients with cystic fibrosis (CF), there is an increasing incidence of some uncommon respiratory pathogens, such as Burkholderia cepacia complex (Bcc), Stenotrophomonas maltophilia, and Achromobacter xylosoxidans. In order to evaluate the prevalence and the clinical impact of these...

  • Antimicrobial activity of alcoholic and aqueous extracts of Vetiveria zizanioides. Devprakash; Srinivasan, K. K.; singh, Sachin kumar; Subburaju, T. // Journal of Pharmacy Research;May2011, Vol. 4 Issue 5, p1343 

    The success of chemotherapy lies in the continuous search for new drugs to counter the challenge posed by resistant strains. Ethanolic and aqueous extracts of plant Vetiveria zizanioides traditionally used in Indian folklore medicine for the treatment of various bacterial and fungal infections...

  • Strict protocols prevent spread of MRSA.  // Hospital Home Health;Nov2009, Vol. 26 Issue 11, p124 

    The article reports on the specific infection control protocols implemented by employees at Northwest Community Home Care in Arlington Heights, Illinois to prevent the spread of methicillin-resistant staphylococcus aureas (MRSA).

  • Guides issued to treat MRSA. Gustafson, Mary // McKnight's Long-Term Care News;Feb2011, Vol. 32 Issue 2, p3 

    The article focuses on the move of the Infectious Diseases Society of America to release its first set of comprehensive guidelines for treating methicillin-resistant staphylococcus aureus (MRSA).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics